CSIMarket - Company, Sector, Industry and Market Analysis

Economy

Durable Goods Orders

Durable Goods orders rebounded in October

U.S. Durable Goods orders grew again after dipping in the last month, but orders excluding volatile transportation sector decreased. That category excludes defense and transportation and gives a better indication of longer-term trends in the private sector.

Durable goods shipments by industry

Durable goods new orders by industry

Factory Orders

Factory orders rebounded in December

U.S. Factory orders grew again after dipping in the last month, but Shipments of durable goods fell by -0.73 % to $543 billions.

Factory shipments by industry

Factory new orders by industry

Gross Domestic Product

Gross Domestic Product grows 2.6 % in the third-quarter

U.S. economy grows to an annual rate of 2.6 %, as the U.S. trade balance improves.

Aei Income And Growth Fund Xxi Limited Partnership

The Top-line plunged at NONE in the fiscal time-frame ending December 31 2022

For the fourth quarter of 2022 NONE profits turned positive of $0.01 per share compare to $-0.14 a year prior and EPS dropped by -99.63 % from $1.64 per share from the prior reporting period.

Revenues faded by -37.649 % to $0.19 millions from $0.31 millions in the comparable reporting period a year prior and sequentially Revenue Tumbled by -49.218 % from $0.38 millions.

Aei Income And Growth Fund Xxi Limited Partnership stock quotes, charts, profile

Aei Income And Growth Fund Xxi Limited Partnership Revenue elevation Rates

Creative Media And Community Trust Corporation

The investors are dealing with 2.957%, growth at CMCT all along the fiscal interval closing Dec 31 2022

For the fourth quarter of 2022 earnings season CMCT Losses have expanded of $-0.39 per share compare to $-0.38 a year ago and EPS improved from $-0.50 per share from the prior financial reporting period.

Revenue grew barely by 2.957 % to $25.87 millions from $25.13 millions in the corresponding financial reporting period a year ago and sequentially Revenues advanced by 4.084 % from $24.85 millions.

Creative Media And Community Trust Corporation Competitors, Market Share

Creative Media And Community Trust Corporation Revenue growth Rates

closeup_By_Jean-Etienne_Minh-Duy_Poirrier_from_Bruxelles_Belgium_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons

Aspira Women S Health Inc

Profitability not reached inspite of bewildering Revenues at the Aspira Women S Health Inc in the financial interval closing Dec 31 2022

For the fourth quarter of 2022 AWH lost money of $-0.04 per share compare to $-0.08 a year before and from $-0.04 per share from the prior reporting season.

Revenues rose widely by 16.316 % to $2.15 millions from $1.85 millions in the comparable reporting season a year before and sequentially Revenues surged by 3.909 % from $2.07 millions.

Aspira Women S Health Inc Suppliers

Aspira Women S Health Inc advance Rates, Profitability, PE

Recently Reported Results

Candel Therapeutics Inc

Underlining the October to December 31 2022 period CADL Diminishing Returns have widen at $-0.15 per share, relative to the results of $1.54 per share a year ago reporting season, In the preceding reporting season CADL realized $-0.30 per share.

Candel Therapeutics Inc Competitors, Market Share

Candel Therapeutics Inc Income Statement, Balance sheets, Cash Flow Statement

Invesco Db G10 Currency Harvest Fund

In the Dec 31 2022 report Invesco Db G10 Currency Harvest Fund reached zero gain at $0.00 per share, opposite of $0.00 per share a year prior financial reporting period, In the prior financial reporting period DBV realized $0.00 per share.

Invesco Db G10 Currency Harvest Fund Suppliers

Galaxy Gaming Inc

Top-line was $5.940523 millions but Topline Up gently at the Galaxy Gaming Inc amid the most recent fiscal period

For the financial span ending December 31 2022 GLXZ realized net deficit per share of $0.00 in proportion to $0.02 a year prior, while Revenues advanced by 4.764 % to $5.94 millions from the same quarter a year prior.

Galaxy Gaming Inc Competitors, Market Share

Galaxy Gaming Inc rise Rates, Profitability, PE

pills_rapid_release_pills_By_Katy_Warner_from_Orlando_FL_USA_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons

Calithera Biosciences Inc

In thefourth quarter of 2022 earnings season operating loss embodied improvement to $-69.209 millions, at the CALA

The shareholders have not hoped for some modifications at the revenue during the the October to December 31 2022 reporting season at the CALA. However, they monitor the company's operating loss that has been at $-7.346 millions, during the matching time.

Calithera Biosciences Inc Customers

Calithera Biosciences Inc Revenue rise Rates

oil_Plataform_By_aherrero_(La_Gaviota_Uploaded_by_ecemaml)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons

Vantage Drilling International

A bounce in Revenues fueled to reduce the deficit, at Vantage Drilling International in the October to December 31 2022 time-frame

Respectable Revenue elevation in the Dec 31 2022 report, by 52.984 % to $76.19 millions fueled to cut losses to $-1.33 per share, from $-1.79 in same the reporting season a year before.

Vantage Drilling International stock quotes, charts, profile

Vantage Drilling International elevation Rates, Profitability, PE

Oil_platform_By_Divulgacao_Petrobras__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons

Surrozen Inc

Surrozen Inc released Revenue of $12.5 millions, in the fiscal span ending December 31 2022

the Biotechnology & Pharmaceuticals company disclosed $12.5 millions, in Revenue in the fiscal span ending December 31 2022.

Surrozen Inc Customers

Surrozen Inc Suppliers

Recently Reported Results

Electronics-Processor-Electricity-Computer-1288717

Aei Income And Growth Fund Xxi Limited Partnership

The Electronic Instruments & Controls company declared a jaw-dropping -37.649 %, in Revenues, over the fiscal fourth quarter of 2022

For the fourth quarter of 2022 earnings season company profitability turned positive of $0.01 per share compare to $-0.14 a year ago and EPS dropped by -99.63 % from $1.64 per share from the prior reporting period.

Revenues faded by -37.649 % to $0.19 millions from $0.31 millions in the similar reporting period a year ago and sequentially Revenue Tumbled by -49.218 % from $0.38 millions.

Aei Income And Growth Fund Xxi Limited Partnership Suppliers

industry_industrial_smoke_smog_manufacturing_steel_chimney_stacks_chimneys-655361

Industrial production

U.S. production output continued to fell

Production by industry

Capacity utilization by industry

Better Therapeutics Inc

The company created great surprise for the investors, displaying an important improvement in most recent fiscal period with operating deficit of $-8.322 millions

Trailing the big players in the Medical Equipment & Supplies sector, some smaller entities are reporting the results. BTTX told it has clinched operating deficit of $-8.322 millions, for the fourth quarter of 2022.

Better Therapeutics Inc Suppliers

pills_blue_By_Tom_Varco_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons

Aptevo Therapeutics Inc

For the October to December 31 2022 period Aptevo Therapeutics Inc decreased a loss per share of $-0.84 per share compare to $-1.28 a year prior and earnings per share improved from $-1.50 per share from the preceding financial reporting period.

Revenues remained unaffected to $0.00 millions from $3.67 millions in the similar financial reporting period a year prior and sequentially Revenue Tumbled from $0.00 millions.

Aptevo Therapeutics Inc Customers

Aptevo Therapeutics Inc Suppliers

Autosample_takes_a_By_Hey_Paul_(originally_posted_to_Flickr_as_image8)_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons

Candel Therapeutics Inc

Concentrating on the October to December 31 2022 time-frame Candel Therapeutics Inc Diminishing Returns have swelled at $-0.15 per share, relative to the results of $1.54 per share a year before reporting season, In the preceding reporting season the Biotechnology & Pharmaceuticals company realized $-0.30 per share.

Candel Therapeutics Inc Competitors, Market Share

Candel Therapeutics Inc rise Rates, Profitability, PE

Producer Price Index

Inflation higher in December 2022

Prices increased on the faster pace again, adding to inflationary worries.

Shopping_in_By_Ramunasjurevicius_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common

Personal Income and Spending

Consumer spending on the rise again in January 2023

Bugatti_Veyron_By_Ritchyblack_Stefan_Krause_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common

Auto Sales

Ford surpasses GM in December

Invesco Db G10 Currency Harvest Fund

In the fourth quarter of 2022 financial report Invesco Db G10 Currency Harvest Fund reached zero gain at $0.00 per share, opposite of $0.00 per share a year prior financial reporting period, In the previous financial reporting period DBV realized $0.00 per share.

Invesco Db G10 Currency Harvest Fund stock quotes, charts, profile

Invesco Db G10 Currency Harvest Fund Suppliers

Allure_of_the_SeasBy_Makele-90_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons

Galaxy Gaming Inc

A modest 4.764%, rise in Revenues at GLXZ during the financial interval closing Dec 31 2022

For the October to December 31 2022 GLXZ realized net loss per share of $0.00 in proportion to $0.02 a year prior, while Revenues advanced by 4.764 % to $5.94 millions from the same reporting period a year prior.

Galaxy Gaming Inc Customers

Galaxy Gaming Inc Revenue rise Rates

Calithera Biosciences Inc

In the most recent fiscal period operating deficit embodied enhancement to $-69.209 millions, at the Calithera Biosciences Inc

The Major Pharmaceutical Preparations sector reporters start to analyze the fourth quarter of 2022 results. Presently those reporters observe operating deficit of $-7.346 millions, from the Calithera Biosciences Inc , which has not stated any top-line so far, for the respective October to December 31 2022 financial reporting period.

Calithera Biosciences Inc Suppliers

Calithera Biosciences Inc Income Statement, Balance sheets, Cash Flow Statement

Vantage Drilling International

Top-line soared and losess have been cut, at the company all along the most recent fiscal period

Strong Revenue rise in the October to December 31 2022, by 52.984 % to $76.19 millions fueled to cut losses to $-1.33 per share, from $-1.79 in similar the reporting season a year before.

Vantage Drilling International Suppliers

Surrozen Inc

The company published Revenue of $12.5 millions, in the financial fourth quarter of 2022

Surrozen Inc revealed $12.5 millions, in Revenue in the financial span closing December 31 2022.

Surrozen Inc Suppliers

Surrozen Inc elevation Rates, Profitability, PE

Sikh_wearing_turban_By_Photography_by_Harkanwal_Singh._(Harkanwal_Singh)__[CC-BY-SA-2.5_(http_creativecommons.org_licenses_by-sa_2.5)]_via_Wikimedia_Common

Ast Spacemobile Inc

Concentrating on the October to December 31 2022 interval ASTS reached balanced books at $0.00 per share, relative to the results of $0.32 per share a year ago reporting period, In the preceding reporting period ASTS realized $-0.18 per share.

Ast Spacemobile Inc stock quotes, charts, profile

Ast Spacemobile Inc elevation Rates, Profitability, PE


Economy Advance Monthly Sales Consumer Price Index CPI Producer Price Index PPI Retail Inventories Personal Income Gross Domestic Product GDP Money Supply Industrial Production Productivity Employment Situation US International Trade Factory Orders Durable Goods Construction Spending Housing Starts Vehicle Unit Sales	Stocks Event Calendar ALPN's Profile Stock Price ALPN's Financials Business Description Fundamentals Charts & Quotes ALPN's News Suppliers ALPN's Competitors Customers & Markets Economic Indicators ALPN's Growth Company Segments	Screening Stock Performance Growth Rates Profitability Valuation Dividend Financial Strength Efficiency Largest Companies Management Effectivness